Finance

Beta
Lists
4208:TYO
UBE Corp
Â¥2,992.00
+1.73%
(+51.00) 1D
Jun 3, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4208...
Open
Â¥2,964
High
Â¥3,006
Low
Â¥2,951
Mkt. cap
317.75B
Avg. vol.
1.40M
Volume
1.04M
Dividend
3.68%
Quarterly dividend
Â¥27
Ex-dividend date
Sep 29, 2025
P/E ratio
12.18
52-wk high
Â¥3,067
52-wk low
Â¥2,184
EPS
Â¥246
Shares outstanding
105.05M
No. of employees
8K
Open
Â¥2,964
High
Â¥3,006
Low
Â¥2,951
Mkt. cap
317.75B
Avg. vol.
1.40M
Volume
1.04M
Dividend
3.68%
Quarterly dividend
Â¥27
Ex-dividend date
Sep 29, 2025
P/E ratio
12.18
52-wk high
Â¥3,067
52-wk low
Â¥2,184
EPS
Â¥246
Shares outstanding
105.05M
No. of employees
8K
News stories
From sources across the web
Profile
UBE Corporation is a Japanese chemical company manufacturing chemicals, plastics, battery materials, pharmaceuticals, cement, construction materials, and machinery. The former company name is Ube Industries, Ltd. The company was founded in 1897 when Sukesaku Watanabe —an industrialist, a member of the House of Representatives of Japan and a deputy mayor of Ube— established Okinoyama Coal Mine, the predecessor of the present Ube industries. Since then, the company has established six core business units: Chemicals & plastics, specialty chemicals & products, cement, pharmaceuticals, machinery and metal products, energy and environment. The company is listed on the Tokyo Stock Exchange and Fukuoka Stock Exchange, and is a constituent of the Nikkei 225 stock index. Ube Industries is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About UBE Corp
CEO-
Employees7.56K
FoundedJun 1897
Headquarters-
SectorChemical industry
Websiteube.com
Last report
May 13, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
130.19B / 135.83B
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
100.46B
112.24B
119.45B
130.19B
Cost of goods sold
79.11B
85.96B
90.00B
103.82B
Cost of revenue
79.11B
85.96B
90.00B
103.82B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.52B
20.87B
23.31B
21.57B
Operating expense
18.52B
20.87B
23.31B
21.57B
Total operating expenses
97.63B
106.83B
113.31B
125.39B
Operating income
2.83B
5.42B
6.13B
4.80B
Other non operating income
-15.00M
-239.00M
1.24B
550.00M
EBT including unusual items
5.87B
8.13B
14.15B
2.58B
EBT excluding unusual items
6.21B
9.70B
14.44B
7.66B
Income tax expense
1.30B
1.22B
4.01B
82.00M
Effective tax rate
22.23%
15.06%
28.33%
3.18%
Other operating expenses
-
-
-
-
Net income
4.36B
6.52B
10.19B
2.80B
Net profit margin
4.34%
5.81%
8.53%
2.15%
Earnings per share
-
-
-
-
Interest and investment income
365.00M
118.00M
304.00M
215.00M
Interest expense
-832.00M
-835.00M
-832.00M
-966.00M
Net interest expenses
-467.00M
-717.00M
-528.00M
-751.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
8.82B
12.52B
13.53B
11.78B
Gain or loss from assets sale
-11.00M
1.47B
356.00M
2.68B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer